LUXAU

Lux Health Tech Acquisition Corp. [LUXAU] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

LUXAU Stock Summary

In the News

LUXAU Financial details

Company Rating
Buy
Market Cap
0
Income
32.56M
Revenue
0
Book val./share
-0.44
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
17.2
Forward P/E
-
PEG
-0.01
P/S
-
P/B
1.05
P/C
-
P/FCF
-
Quick Ratio
0.02
Current Ratio
0.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.79
EPS next Y
-
EPS next Q
-
EPS this Y
-22556.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-61.11%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
1.54%
Inst Trans
0.76%
ROA
6%
ROE
6%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.87-10.41
52W High
-
52W Low
-
RSI
-
Rel Volume
0.02
Avg Volume
4.45K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

LUXAU Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2020-12-31 2021-12-31
2.02K2.02K
Revenue per share
00
Net income per share
-0.011.28
Operating cash flow per share
-0.010
Free cash flow per share
-0.010
Cash per share
8.010.01
Book value per share
7.74-0.64
Tangible book value per share
7.747.36
Share holders equity per share
7.74-0.64
Interest debt per share
0-0.66
Market cap
463.59M422.62M
Enterprise value
462.96M422.21M
P/E ratio
-1.89K7.63
Price to sales ratio
00
POCF ratio
-800.28-599.85K
PFCF ratio
-800.28-599.85K
P/B Ratio
1.39-15.38
PTB ratio
1.39-15.38
EV to sales
00
Enterprise value over EBITDA
-1.89K15.58
EV to operating cash flow
-799.18-599.25K
EV to free cash flow
-799.18-599.25K
Earnings yield
00.13
Free cash flow yield
00
Debt to equity
00
Debt to assets
00
Net debt to EBITDA
2.61-0.02
Current ratio
5.710.71
Interest coverage
00.04
Income quality
2.370
Dividend Yield
00
Payout ratio
00
Sales general and administrative to revenue
00
Research and developement to revenue
00
Intangibles to total assets
00
Capex to operating cash flow
00
Capex to revenue
00
Capex to depreciation
00
Stock based compensation to revenue
00
Graham number
0.994.29
ROIC
00.09
Return on tangible assets
00.16
Graham Net
7.73-0.64
Working capital
896.47K-269.81K
Tangible asset value
333.83M317.51M
Net current asset value
-11.18M-27.51M
Invested capital
00
Average receivables
00
Average payables
0138.12K
Average inventory
00
Days sales outstanding
00
Days payables outstanding
00
Days of inventory on hand
00
Receivables turnover
00
Payables turnover
00
Inventory turnover
00
ROE
0-2.01
Capex per share
00

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
0.160.060.230.360.14
Operating cash flow per share
-0.0100.01-0.010
Free cash flow per share
-0.0100.01-0.010
Cash per share
0.0200.0100
Book value per share
24.18-0.75-0.64-0.46-0.44
Tangible book value per share
24.187.257.367.549.56
Share holders equity per share
24.18-0.75-0.64-0.46-0.44
Interest debt per share
00-0.11-0.18-0.15
Market cap
126.82M423.06M422.63M425.21M341.21M
Enterprise value
126.54M422.93M422.21M425.08M341.18M
P/E ratio
15.7640.0310.826.8718.19
Price to sales ratio
00000
POCF ratio
-914.56-2.81K856.18-1.47K-3.3K
PFCF ratio
-914.56-2.81K856.18-1.47K-3.3K
P/B Ratio
0.41-13.08-15.38-21.38-22.4
PTB ratio
0.41-13.08-15.38-21.38-22.4
EV to sales
00000
Enterprise value over EBITDA
62.92160.0586.8855.9872.22
EV to operating cash flow
-912.55-2.81K855.33-1.47K-3.3K
EV to free cash flow
-912.55-2.81K855.33-1.47K-3.3K
Earnings yield
0.020.010.020.040.01
Free cash flow yield
00000
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
-0.14-0.05-0.09-0.02-0.01
Current ratio
1.210.440.710.380.13
Interest coverage
000.010.040.09
Income quality
-0.07-0.060.1-0.04-0.02
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
9.241.021.81.931.16
ROIC
00.0100.030.03
Return on tangible assets
0.010.010.030.040.01
Graham Net
-2.75-0.75-0.64-0.47-0.46
Working capital
84.47K-242.1K-269.81K-547.62K-1.05M
Tangible asset value
310.01M312.65M317.51M325.11M329.8M
Net current asset value
-35M-32.37M-27.51M-19.94M-15.74M
Invested capital
00000
Average receivables
00000
Average payables
118.66K199.02K229.88K284.55K322.77K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0.01-0.08-0.36-0.78-0.31
Capex per share
00000

LUXAU Frequently Asked Questions

What is Lux Health Tech Acquisition Corp. stock symbol ?

Lux Health Tech Acquisition Corp. is a US stock , located in New york of Ny and trading under the symbol LUXAU

What is Lux Health Tech Acquisition Corp. stock quote today ?

Lux Health Tech Acquisition Corp. stock price is $- today.

Is Lux Health Tech Acquisition Corp. stock public?

Yes, Lux Health Tech Acquisition Corp. is a publicly traded company.

Something similar

Top by Market Cap
Check Those
Similar Market Cap